Skip to main content
MedPathMedPath Home
Clinical Trials/jRCTs072200014
jRCTs072200014
Completed
Not Applicable

Efficacy of Nasal High Flow therapy on the coordination between breathing and swallowing of saliva during daytime nap in COPD patients. A single center, randomized crossover controlled study.

Not provided0 sites15 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Status
Completed
Enrollment
15
Primary Endpoint
-
OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsRecords & IdentifiersSimilar Trials

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomized Controlled Trial
Intervention Model
Crossover Assignment
Primary Purpose
Treatment Purpose
Masking
Open(masking Not Used)

Eligibility Criteria

Ages
40age old over to No limit (—)
Sex
All

Inclusion Criteria

  • •The severity of COPD is moderate (GOLD2) or more.
  • •Age: At the time of obtaining consent, an adult patient 40 years or older
  • •Gender: Any
  • •Hospitalization / Outpatient: Outpatient only
  • •Patients who have been given sufficient explanations to participate in this study and have given their full understanding and informed consent from the patient

Exclusion Criteria

  • •Patients who cannot breathe nose
  • •Patients with a history of pneumothorax
  • •Patients with active malignancy
  • •Patients with acute disease (such as acute myocardial infarction)
  • •Patients currently diagnosed with asthma (Patients who have a history of asthma but are currently diagnosed with COPD are eligible for inclusion.)
  • •Patients who have been diagnosed with obstructive sleep apnea in the past and who are strongly suspected clinically
  • •Patients already using NHF
  • •Patients who are using non-invasive ventilation (NIV) at night
  • •Patients with severe disease of the kidney, liver or circulatory system
  • •Patients who are considered inappropriate by the Principal Investigator

Outcomes

Primary Outcomes

-

Rate of expiratory phase after swallowing saliva

Secondary Outcomes

  • Time-weighted average value of tcpO2
  • Time-weighted average value of tcpCO2
  • Time-weighted average value of SpO2
  • Time-weighted average respiratory rate

Investigators

Sponsor
Not provided

Similar Trials

Recruiting
Not Applicable
Efficacy of Nasal High Flow therapy on the coordination between breathing and swallowing of saliva during daytime nap in COPD patients.COPD
JPRN-jRCTs072200014Ayuse Takao15
Completed
Phase 2
The assessment of the efficacy of Nasal High Flow System during sedation for the operatio
JPRN-UMIN000019697JCHO Osaka Hopital50
Not yet recruiting
Not Applicable
Efficacy of nasal high flow therapy for respiratory management in patients after sagittal splitting ramus osteotomy researchafter sagittal splitting ramus osteotomy
JPRN-UMIN000041116Tokyo medical and dental university graduate school of medical and dental sciences dental anesthesiology and olofacial pain management70
Completed
Not Applicable
The effect of nasal high flow therapy on the recovery of pulmonary function in the early postoperativ period
JPRN-UMIN000011686wajima city hospital40
Completed
Not Applicable
Short term effects of Nasal High Flow Therapy on autonomic nervous system function in patients with pulmonary arterial hypertension.I27.0Primary pulmonary hypertension
DRKS00013906Department für Neurologie - Klinik für Schlafmedizin und neuromuskuläre Erkrankungen Universitätsklinikum Münster12